SCHEMBL5587480

SCHEMBL5587480

CCc1ccc(N=C(C)c2cccc(C(C)=Nc3ccc(CC)cc3CC)n2)c(CC)c1.CCc1ccc(N=C(C)c2cccc(C(C)=Nc3ccc(CC)cc3CC)n2)c(CC)c1.[Co+].[Co+].[O-]c1c([O-])c2ccccc2c2ccccc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 10/20 0.35
TP53 P04637 1/20 0.33
CYP2D6 P10635 1/20 0.33
TSHR P16473 1/20 0.33
THPO P40225 1/20 0.33
MTOR P42345 1/20 0.33
MAPT P10636 3/20 0.33
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
PMP22 Q01453 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
MAPK1 P28482 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
CYP1A2 P05177 2/20 0.31
CYP2A6 P11509 1/20 0.31
POLB P06746 1/20 0.30
AGTR1 P30556 1/20 0.30
KDM4E B2RXH2 1/20 0.30
RECQL P46063 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5588047 0.88 SIGMAR1 (0.39) SIGMAR1KMT2AMEN1MAPK1SMN1; SMN2
SCHEMBL5588043 0.88 SIGMAR1 (0.39) SIGMAR1KMT2AMEN1MAPK1SMN1; SMN2
SCHEMBL5586653 0.87 SIGMAR1 (0.39) SIGMAR1KMT2AMEN1MAPK1SMN1; SMN2
SCHEMBL5693601 0.81 GABRA1 (0.33) KMT2ALMNASMN1; SMN2CYP1A2POLB
SCHEMBL5693760 0.79 MAPT (0.47) SIGMAR1TSHRMAPTKMT2AMEN1
SCHEMBL5693710 0.75 HDAC6 (0.38) SIGMAR1TSHRMAPTKMT2AMEN1
SCHEMBL5693681 0.75 SMN1; SMN2 (0.34) SIGMAR1MAPTKMT2AMEN1LMNA
SCHEMBL5144785 0.74 SIGMAR1 (0.45) SIGMAR1TSHRMAPTKMT2ALMNA
SCHEMBL5144787 0.74 SIGMAR1 (0.45) SIGMAR1TSHRMAPTKMT2ALMNA
SCHEMBL5693752 0.73 CYP1A2 (0.35) MAPTKMT2AMEN1SMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 SIGMAR1 1143/4885TP53 3753/4885CYP2D6 1324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.